Forwin Pharmaceutical Private Limited
About Forwin Pharmaceutical Private Limited
Data last updated:
Forwin Pharmaceutical Private Limited is a private limited company based in Jalna, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 September 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2022PTC391386.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹20,000. It is led by directors including Manisha Amol Sarkate and Atul Shankar Jadhao.
Its last annual general meeting (AGM) was held on 22 November 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at C/O Pushpa Jadhav Nr Santkrupa Hospital Mantha Chaufuli At Choudhari Nagar, Jalna, Maharashtra, India – 431203.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.15 Lakh. For the same year it recorded EBITDA of ₹245 (EBITDA margin 0.2%).
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Pushpa Jadhav Nr Santkrupa Hospital Mantha Chaufuli At Choudhari Nagar, Jalna, Maharashtra, India – 431203
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Forwin Pharmaceutical Private Limited
The main business activity of Forwin Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Forwin Pharmaceutical Private Limited FY 2023 filings available
Forwin Pharmaceutical Private Limited reported revenue of ₹1.15 Lakh for FY 2023.
Financial Statement Summary of Forwin Pharmaceutical Private Limited
| Metrics | FY 2022-23 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | •••• |
| Other Income | •••• |
| Total Revenue | •••• |
| Cost of Materials Consumed | •••• |
| Employee Benefit Expense | •••• |
| Finance Costs | •••• |
| Depreciation and Amortisation | •••• |
| Other Expenses | •••• |
| Total Expenses | •••• |
| EBITDA | ₹245 |
| Profit Before Tax | •••• |
| Tax Expense | •••• |
| Net Profit (PAT) | •••• |
| Balance Sheet | |
| Share Capital | •••• |
| Reserves and Surplus | •••• |
| Net Worth (Total Equity) | •••• |
| Long-term Borrowings | •••• |
| Short-term Borrowings | •••• |
| Trade Payables | •••• |
| Total Liabilities | •••• |
| Fixed Assets | •••• |
| Investments | •••• |
| Inventories | •••• |
| Trade Receivables | •••• |
| Cash and Bank Balance | •••• |
| Total Assets | •••• |
Financial Ratios of Forwin Pharmaceutical Private Limited
| Metrics | FY 2022-23 |
|---|---|
| Profitability | |
| EBITDA Margin | 0.2% |
| Net Profit Margin | •••• |
| Return on Equity (ROE) | •••• |
| Return on Capital Employed (ROCE) | •••• |
| Return on Assets (ROA) | •••• |
| Liquidity and Debt | |
| Current Ratio | •••• |
| Quick Ratio | •••• |
| Debt-to-Equity Ratio | •••• |
| Interest Coverage Ratio | •••• |
| Efficiency and Growth | |
| Asset Turnover | •••• |
| Receivable Days | •••• |
| Payable Days | •••• |
| Inventory Days | •••• |
| Revenue Growth | •••• |
| Net Profit Growth | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Forwin Pharmaceutical are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Forwin Pharmaceutical Private Limited
Forwin Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rynish Pharmaceuticals Private Limited | ₹1.17 Lakh (FY 2025) | •••• | •••• | -98.0% | •••• | Mumbai, Maharashtra, India |
| Anatolis Pharmaceuticals Private Limited | ₹1.16 Lakh (FY 2018) | •••• | •••• | •••• | Miraroad East, Maharashtra, India | |
| Nano Biotech Private Limited | ₹1.15 Lakh (FY 2024) | •••• | •••• | -66.0% | •••• | Punjab, India |
| Srinaas Chemicals and Pharmaceuticals Private Limited | ₹1.15 Lakh (FY 2024) | •••• | •••• | •••• | Bibinagar, Telangana, India | |
| Airmid Healthtech Private Limited | ₹1.15 Lakh (FY 2021) | •••• | •••• | •••• | Badlapur East, Maharashtra, India | |
| Forwin Pharmaceutical Private Limited this company | ₹1.15 Lakh (FY 2023) | •••• | •••• | •••• | Jalna, Maharashtra, India | |
| Affomed Healthcare Private Limited | ₹1.14 Lakh (FY 2016) | •••• | •••• | -84.0% | •••• | Navi Mumbai, Maharashtra, India |
| Delfina Pharma Private Limited | ₹1.14 Lakh (FY 2023) | •••• | •••• | -1.0% | •••• | Patna, Bihar, India |
| Oshid Pharmaceuticals Pvt Ltd | ₹1.14 Lakh (FY 2025) | •••• | •••• | -78.0% | •••• | Punjab, India |
| Hesse Pharmaceuticals Private Limited | ₹1.14 Lakh (FY 2025) | •••• | •••• | -97.0% | •••• | Pathankot, Punjab, India |
| Reactionbox Engineering Private Limited | ₹1.14 Lakh (FY 2019) | •••• | •••• | -6.0% | •••• | Kamptee, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Forwin Pharmaceutical by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Forwin Pharmaceutical Private Limited
Forwin Pharmaceutical has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manisha Amol Sarkate | Director | 05 Aug 2023 | 3 Years 2 Months | Current |
| Atul Shankar Jadhao | Director | 30 Sep 2022 | 4 Years 0 Months | Current |
| Shweta Atul Jadhao | Director | 30 Sep 2022 | 4 Years 0 Months | Current |
Charges & Borrowings of Forwin Pharmaceutical Private Limited
Forwin Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Forwin Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Forwin Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Forwin Pharmaceutical Private Limited
Forwin Pharmaceutical Private Limited has 3 board changes on record since 2022: 3 appointments. The latest: Manisha Amol Sarkate was appointed as Director on 05 Aug 2023.
Credit Ratings, Litigation & Regulatory Alerts for Forwin Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Forwin Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Forwin Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Forwin Pharmaceutical Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Forwin Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Forwin Pharmaceutical Private Limited
Forwin Pharmaceutical is an active private limited company based in Jalna, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 September 2022 (4+ years old) and is registered under CIN U24230MH2022PTC391386.
Forwin Pharmaceutical reported revenue of ₹1.15 Lakh for FY 2023.
Forwin Pharmaceutical has 3 current directors:
- Manisha Amol Sarkate - Director
- Atul Shankar Jadhao - Director
- Shweta Atul Jadhao - Director
Forwin Pharmaceutical reported EBITDA of ₹245 (EBITDA margin 0.2%) for FY 2023, as per its filed financial statements.
The CIN (Corporate Identification Number) of Forwin Pharmaceutical is U24230MH2022PTC391386. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Forwin Pharmaceutical was incorporated on 30 September 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Forwin Pharmaceutical by revenue are Rynish Pharmaceuticals Private Limited, Anatolis Pharmaceuticals Private Limited, Nano Biotech Private Limited, Srinaas Chemicals and Pharmaceuticals Private Limited, Airmid Healthtech Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Manisha Amol Sarkate was appointed as Director on 05 Aug 2023. Atul Shankar Jadhao was appointed as Director on 30 Sep 2022. Shweta Atul Jadhao was appointed as Director on 30 Sep 2022.
The registered office of Forwin Pharmaceutical is at CO Pushpa Jadhav Nr Santkrupa Hospital Mantha Chaufuli At Choudhari Nagar, Jalna, Maharashtra, India – 431203.
Forwin Pharmaceutical has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹20,000.
Forwin Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.